The multi-year partnership will deliver significant savings by driving distribution efficiencies to their nationwide locations over the term of the agreement. CTCA corporate supply chain manager Clinton Hazziez
The round was led by Vivo Capital and included other new investors Frazier Healthcare Ventures, OrbiMed Advisors, Adams Street Partners, RA Capital Management, Caxton Alternative Management, Hopen Life
The trial will investigate the use of Ovasave, an antigen-specific regulatory T (Ag-Treg) autologous cell-based immunotherapy for the treatment of patients with moderate to severe refractory Crohn’s disease.
Neptune may appeal this decision, but cannot submit any additional evidence or claim amendments. Enzymotec president and CEO Dr Ariel Katz noted that this final decision by the
Foamix now has a total of 25 issued US Patents, 61 issued worldwide and 126 patents pending. These new patents, which were issued between August 2013 and January
CFFT is the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation. This agreement allows Alcresta to accelerate the development of its nutrition technology and advance
The featured article describes the outcome in 52 advanced cancer patients treated with Xilonix, XBiotech’s novel, non-cytotoxic, anti-tumor therapy. The so called true human antibody therapy was reported
MultiCorp International CEO Paul D. Lisenby noted that the company is extremely excited to have such a qualified and experienced group to assist the company in mapping out
Under the licensing agreement entered into on 6 March 2008, Amgen was granted exclusive rights to develop and commercialize Kyowa Hakko Kirin’s humanized monoclonal antibody mogamulizumab in all
Coldstream hosted FDA authorities from 8 April – 17 April 2014, at its manufacturing facility in Lexington. The site audit reviewed quality systems to ensure compliance with current
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.